Description
EMPIGET M 12.5/1000mg, supplied in a convenient pack of 14 tablets, offers a powerful dual-action approach for adults managing type 2 diabetes. Each tablet combines Empagliflozin 12.5mg, an SGLT2 inhibitor that helps kidneys excrete excess glucose from the body, with Metformin Hydrochloride 1000mg, which reduces glucose production and improves the body’s sensitivity to insulin. This synergistic combination effectively lowers blood sugar levels. Beyond glycemic control, EMPIGET M 12.5/1000mg also provides significant benefits by reducing the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in eligible patients. Used as an adjunct to diet and exercise, it offers comprehensive support for long-term diabetes management
